top of page
Zalcitabine

Mechanism of action:
Zalcitabine is a nucleoside reverse transcriptase inhibitor and a deoxycytidine analog. After entering the cell, it is sequentially phosphorylated by host cell kinases into zalcitabine-5'-triphosphate, its active form. Zalcitabine-5'-triphosphate competes with dCTP and is mistakenly incorporated into elongating viral DNA by HIV reverse transcriptase. Because zalcitabine lacks a 3'-OH group, its incorporation results in termination of viral DNA synthesis.
Reference(s):
1. Shelton MJ et al. (1993). Zalcitabine. Ann Pharmacother.
2. Devineni D et al. (1995). Zalcitabine. Clinical pharmacokinetics and efficacy. Clin Pharmacokinet.
bottom of page
